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both eliminate tolerance and impair the clearance of theSHIP, TGF-,
pyrogen from the blood (Beeson, 1947b). Noting the lackand Endotoxin Tolerance of serospecificity (tolerance prevented a response to
pyrogens prepared from almost any gram-negative or-
ganism) and the recovery of competence to mount a
febrile response within a few weeks after pyrogen injec-
Research into the biology of endotoxin (aka lipopoly- tions were terminated (a time point at which antibodies
saccharide; LPS) began well over 100 years ago (Pfeif- against capsular polysaccharides were still abundant in
fer, 1892) and has had many unexpected turns. The serum), Beeson and others discounted a role for anti-
phenomenon of endotoxin tolerance was among these bodies against the pyrogen in the development of endo-
and has engendered immense curiosity over the years. toxin tolerance, considering instead that a cellular
Sly and colleagues (this issue of Immunity) have taken mechanism was at play. Later workers concluded that
an important step toward understanding the phenom- “endogenous pyrogens” (i.e., pyrogenic cytokines) were
enon of endotoxin tolerance and have enhanced our produced largely by mononuclear phagocytic cells in
comprehension of LPS signaling as a whole by demon- response to LPS; hence, it made sense to think that the
strating that the cytosolic phosphatase SHIP is re- ability to develop tolerance was an inherent property of
quired to permit the development of an LPS-refractory these cells. The fact that LPS tolerance could be ob-
state in macrophages and mice. served in cultured macrophages was a commonplace
observation that reinforced this view. The discoveries
Endotoxin tolerance was a phenomenon first noticed in that TNF (Beutler et al., 1985) and interferon- (Karaghio-
humans rather than in animals. In the 1930s and 1940s, soff et al., 2003) mediate much of the toxicity of LPS
typhoid vaccine was administered to patients with neu- have, in turn, given relevant endpoints to follow in as-
rosyphilis to induce fever, which was known to slow sessing LPS tolerance both in vivo and in vitro.
the progress of T. pallidum infection within the central The cellular mechanism for endotoxin tolerance is of
nervous system. With repeated administration, the vac- obvious interest, because dampening the LPS response
cine showed progressive loss of efficacy as a pyrogen, may have important clinical utility, most notably in se-
and an escalation of dose was required to achieve a vere gram-negative infections. Hence, the biochemical
therapeutic effect: a phenomenon closely investigated basis of the “natural” inhibition of LPS signaling that
by Beeson (Beeson, 1947a). He established a rabbit occurs in mononuclear phagocytes has attracted much
model of tolerance and concluded that tolerance arose attention. But for many years, the biochemical basis
from an interaction between LPS and reticuloendothelial of LPS tolerance remained obscure and only now is a
cells, since “reticuloendothelial blockade” with Thoro- detailed understanding of the phenomenon beginning
to emerge.trast (colloidal thorium dioxide) or trypan blue could
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The identification of the LPS receptor, revealed as The topic of LPS tolerance is a very large one and
TLR4 by the positional cloning of the Lps locus (Poltorak cannot be fully elucidated in a single publication, though
et al., 1998), has offered a chance to probe various Sly and colleagues have made a significant advance.
aspects of the LPS signaling pathway in an effort to Among the questions raised by this important piece of
decipher the mechanism of feedback inhibition. It has work, we may wonder exactly how TGF- is induced by
become clear that there are two major signaling path- LPS (i.e., via the MyD88/Tirap pathway or via the TRIF/
ways that emanate from the LPS receptor. One of these TRAM pathway or both). Is crosstolerance (the develop-
is the MyD88-dependent signaling pathway, which de- ment of tolerance to LPS induced by TLR2 ligands, for
pends on the adapters MyD88 and Tirap. The other is the example) (Sato et al., 2000) dependent upon SHIP just
MyD88-independent signaling pathway, which depends as tolerance is? If so, we might conclude that only the
on the adapters TRIF and TRAM. Both pathways lead MyD88-dependent pathway is important for SHIP acti-
to the activation of NF-B via activation of TRAF-6. But vation. And why does SHIP-induced tolerance seem to
the MyD88-independent pathway is unique in that it also supersede tolerance induced by IRAK-M and SOCS-1?
leads to the activation of IRF-3 and to the production Clearly there is room for much additional work now that
of type I interferons (Hoebe et al., 2003; Yamamoto et a foothold is has been made.
al., 2003).
Feedback inhibition might potentially occur at several
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Department of Immunology, IMM31causes a fall in TLR4-encoding mRNA in macrophages
The Scripps Research Institute(Poltorak et al., 1998; Nomura et al., 2000), but this may
10550 N. Torrey Pines Roadbe a species-limited phenomenon rather than a general
La Jolla, CA 92037one. IRAK-M, activated by traffic through the LPS signal-
ing pathway, is known to have an inhibitory effect on
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